VolitionRX Limited

(NYSE:VNRX)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Contact Information

Website: www.volition.com
Email: investorrelations@volition.com
Main Phone: +1 646 650-1351
Address: 13215 Bee Cave Parkway
Address 2: Suite 125, Galleria Oaks B
State: TX
City / Town: Austin
Country: US
Postal Code: 78738

Issuer Information

Exchange: AMX
CEO: Cameron John. Reynolds
Employees: 65
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A